Substance use patterns among a global sample of transgender and non-binary people during the COVID-19 pandemic

Table 4 Descriptive statistics of changes in substance use since the COVID-19 pandemic among transgender participants

	Transfeminine n (%)	Non-binary n (%)	Transmasculine n (%)	P value
Change in at least one substance used since COVID-19				0.63
Individuals responding to at least one substance change question	n = 120	n = 350	n = 39
Increase in at least one	63 (52.5%)	194 (55.4%)	19 (48.7%)
No increase in at least one	57 (47.5%)	156 (44.6%)	20 (51.3%)
Change in tobacco use since COVID-19				0.92
Decreased	18 (14.3%)	39 (12.3%)	5 (13.9%)
No change	69 (54.8%)	167 (52.7%)	18 (50.0%)
Increased	39 (31.0%)	111 (35.0%)	13 (36.1%)
Change in alcohol use since COVID-19				0.52
Decreased	58 (26.4%)	162 (27.5%)	17 (23.9%)
No change	133 (60.5%)	331 (56.1%)	39 (54.9%)
Increased	29 (13.2%)	97 (16.4%)	15 (21.1%)
Change in cannabis use since COVID-19				0.42
Decrease	6 (24.0%)	19 (23.2%)	3 (33.3%)
No change	7 (28.0%)	38 (46.3%)	3 (33.3%)
Increased	12 (48.0%)	25 (30.4%)	3 (33.3%)

Due to the survey skip pattern, only individuals who reported prior substance use in the last 6 months were asked questions about change in substance use. Therefore, it was not possible to conduct multiple imputation by chained equation on samples to account for missingness. COVID-19 novel coronavirus disease 2019
Chi-squared tests were conducted for categories with ≥ 5 respondents, while Fisher’s exact tests were conducted for categories with < 5 respondents (transmasculine participants reporting a change in cannabis use)

ISSN: 2731-913X